Elranatamab-induced changes in soluble BCMA.
PD
DISEASE
BCMA, B-cell maturation antigen; CR, complete response; MR, minimal response; PD, progressive disease; PR, partial response; QW, once weekly; sBCMA, soluble B-cell maturation antigen; sCR, stringent complete response; SD, stable disease; VGPR, very good partial response.
